Survey results suggest Black patients face greater barriers to IBD treatment
SAN DIEGO — Black patients with inflammatory bowel disease were more likely to use older therapies and face continued barriers to effective care, according to survey results presented at Digestive Disease Week 2022.“We need to provide education to all patients with IBD and engage each patient in shared decision-making,” Adjoa Anyane-Yeboa, MD, a gastroenterologist at Massachusetts General Hospital and Harvard Medical School, told Healio. “We determined that Black patients in our study wanted more information about the risks and benefits of medications and moreRead More
